» Articles » PMID: 30065253

The Reciprocal Interplay Between TNFα and the Circadian Clock Impacts on Cell Proliferation and Migration in Hodgkin Lymphoma Cells

Overview
Journal Sci Rep
Specialty Science
Date 2018 Aug 2
PMID 30065253
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

A bidirectional interaction between the circadian network and effector mechanisms of immunity brings on a proper working of both systems. In the present study, we used Hodgkin lymphoma (HL) as an experimental model for a type of cancer involving cells of the immune system. We identified this cancer type among haematological malignancies has having a strong differential expression of core-clock elements. Taking advantage of bioinformatics analyses and experimental procedures carried out in III- and IV-stage HL cells, and lymphoblastoid B cells, we explored this interplay and bear out diverse interacting partners of both systems. In particular, we assembled a wide-ranging network of clock-immune-related genes and pinpointed TNF as a crucial intermediary player. A robust circadian clock hallmarked III-stage lymphoma cells, differently from IV-stage HL cells, which do not harbour a properly functioning clockwork. TNF and circadian gene modulation impacted on clock genes expression and triggered phenotypic changes in lymphoma cells, suggesting a crucial involvement of core-clock elements and TNF in the physiopathological mechanisms hastening malignancy. Our results move forward our understanding of the putative role of the core-clock and TNF in the pathobiology of Hodgkin lymphoma, and highlight their influence in cellular proliferation and migration in lymphatic cancers.

Citing Articles

Basic helix-loop-helix ARNT like 1 regulates the function of immune cells and participates in the development of immune-related diseases.

Shao F, Wang Z, Ye L, Wu R, Wang J, Yu Q Burns Trauma. 2025; 13():tkae075.

PMID: 39830193 PMC: 11741524. DOI: 10.1093/burnst/tkae075.


The circadian clock circuitry modulates leukemia initiating cell activity in T-cell acute lymphoblastic leukemia.

Murgo E, De Santis E, Sansico F, Melocchi V, Colangelo T, Padovano C J Exp Clin Cancer Res. 2023; 42(1):218.

PMID: 37620852 PMC: 10464343. DOI: 10.1186/s13046-023-02799-7.


Circadian rhythm as a key player in cancer progression as well as a therapeutic target in -positive advanced gastric cancer treatment.

Wang S, Khan S, Nabi G, Li H Front Oncol. 2023; 13:1240676.

PMID: 37503323 PMC: 10369080. DOI: 10.3389/fonc.2023.1240676.


Circadian Oscillations in Skin and Their Interconnection with the Cycle of Life.

Salazar A, von Hagen J Int J Mol Sci. 2023; 24(6).

PMID: 36982706 PMC: 10051430. DOI: 10.3390/ijms24065635.


Circadian Rhythm Dysregulation and Leukemia Development: The Role of Clock Genes as Promising Biomarkers.

Sanford A, da Cunha L, Machado C, DE Pinho Pessoa F, Silva A, Ribeiro R Int J Mol Sci. 2022; 23(15).

PMID: 35897788 PMC: 9332415. DOI: 10.3390/ijms23158212.


References
1.
Yoshida K, Nakai A, Kaneshiro K, Hashimoto N, Suzuki K, Uchida K . TNF-α induces expression of the circadian clock gene Bmal1 via dual calcium-dependent pathways in rheumatoid synovial cells. Biochem Biophys Res Commun. 2017; 495(2):1675-1680. DOI: 10.1016/j.bbrc.2017.12.015. View

2.
Kiessling S, Cermakian N . The tumor circadian clock: a new target for cancer therapy?. Future Oncol. 2017; 13(29):2607-2610. DOI: 10.2217/fon-2017-0456. View

3.
Bornstein S, Licinio J, Tauchnitz R, Engelmann L, Negrao A, Gold P . Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab. 1998; 83(1):280-3. DOI: 10.1210/jcem.83.1.4610. View

4.
Kiessling S, Beaulieu-Laroche L, Blum I, Landgraf D, Welsh D, Storch K . Enhancing circadian clock function in cancer cells inhibits tumor growth. BMC Biol. 2017; 15(1):13. PMC: 5310078. DOI: 10.1186/s12915-017-0349-7. View

5.
Kramer A, Yang F, Snodgrass P, Li X, Scammell T, Davis F . Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signalling. Novartis Found Symp. 2004; 253:250-62. View